Stephen Abel
Allegheny Health Network · 104 works · 718 citations · h-index 17
Top works
- Stereotactic Body Radiation Therapy in Early-Stage NSCLC: Historical Review, Contemporary Evidence and Future Implications
- Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation
- Patterns of care and outcomes in small cell carcinoma of the prostate: A national cancer database analysis
- Local failure and acute radiodermatological toxicity in patients undergoing radiation therapy with and without postmastectomy chest wall bolus: Is bolus ever necessary?
- Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma
- Urachal carcinoma: A novel staging system utilizing the National Cancer Database
- Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
- Intensity-modulated radiation therapy in early stage squamous cell carcinoma of the larynx: treatment trends and outcomes
- Utilization of Adjuvant Radiotherapy for Resected Colon Cancer and Its Effect on Outcome
- The role of adjuvant therapy for atypical bronchopulmonary carcinoids
- National trends in radiation dose escalation for glioblastoma
- Stereotactic ablative radiation therapy versus conventionally fractionated radiation therapy for stage I small cell lung cancer
- Principles and Applications of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy
- Factors associated with treatment receipt and overall survival for patients with locally advanced large cell neuroendocrine carcinoma of the lung: A National Cancer Database analysis
- Trends in intensity-modulated radiation therapy use for rectal cancer in the neoadjuvant setting: a National Cancer Database analysis
- Utilization of Stereotactic Ablative Body Radiation Therapy for Intact Renal Cell Carcinoma: Trends in Treatment and Predictors of Outcome
- Surgical resection versus stereotactic body radiation therapy in early stage bronchopulmonary large cell neuroendocrine carcinoma
- Trends in Radiation Fractionation for Bone Metastases: A Contemporary Nationwide Analysis
- Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome
- Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy10 enough?